Medicament (3004909231)
CN → US| HS编码 | 关税税率 | 原产国 | 目的国 | 文档 |
|---|---|---|---|---|
| 3003490000 | 10.0% | CN | US | 官方文档 |
| 3003900190 | 10.0% | CN | US | 官方文档 |
| 3004490050 | 10.0% | CN | US | 官方文档 |
| 3004490070 | 10.0% | CN | US | 官方文档 |
| 3004490040 | 10.0% | CN | US | 官方文档 |
商品图片
AI分析
💊 Medicament (Medicament (3004909231))
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Entry Strategy
📌 I. Product Definition & Classification: Do You Truly Understand "Medicament"?
Medicament, in international trade, refers to any substance or preparation intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals. It is a broad category that encompasses everything from simple tablets and capsules to complex injectables and topical ointments.
In the context of HS Code classification (Harmonized System), "Medicament" is not a single code but a functional description that must be mapped to specific subheadings based on: 1. Form of Presentation: Is it mixed with other substances? Is it in dosage forms (e.g., tablets, capsules)? 2. Active Ingredients: Does it contain alkaloids or derivatives? Is it mixed with other therapeutic substances? 3. Packaging: Is it in immediate packings for retail sale?
⚠️ Key Distinction:
- If the product is a pure substance not yet mixed with other therapeutic agents → May fall under Chapter 29 (Organic Chemicals).
- If the product is mixed with other substances and prepared for therapeutic/preventive use → Falls under Chapter 30 (Pharmaceutical Products).
- Most "Medicaments" imported commercially are pre-mixed and packaged, thus falling under 3003 (Non-dosage forms) or 3004 (Dosage forms).
📦 II. HS Code Classification Details (Based on Provided Data)
The provided data indicates five potential HS Codes for the commodity name "Medicament". All codes carry a 10% Total Tax Rate due to Section 122 tariffs (IEEPA). Below is the detailed breakdown of why each code applies.
| HS Code | Product Description | Classification Logic (Based on Provided Data) | Key Distinction |
|--------|--------------------------|---------------------------------------------|
| 3003.49.00.00 | Medicaments (Mixed/Unmixed) containing alkaloids or derivatives | Summary: Matches the definition of "Medicament" by purpose. Since the name doesn't specify ingredients, it is inferred to belong to alkaloid-containing drugs unless material/shape conflicts arise. | Alkaloid-Containing: Often includes certain opioids, quinine, or other specific bioactive compounds not in dosage form or specific mixtures. |
| 3003.90.01.90 | Other Medicaments (Mixed/Unmixed) | Summary: The product is explicitly a "Medicament" for therapeutic/preventive use. Since specific chemical composition or packaging isn't noted, the "Other" fallback rule applies. No material/shape conflicts exist. | General/Mixed Medicament: A broader category for medicaments that do not fit the specific alkaloid or other narrow definitions of 3003. |
| 3004.49.00.50 | Medicaments Put Up in Measured Doses or Retail Packings | Summary: The name "Medicament" directly points to its intended use (therapy/prevention), which aligns perfectly with the code's purpose definition. | Dosage Forms: Implies the product is already prepared for administration (e.g., tablets, capsules, pills) or retail sale. |
| 3004.49.00.70 | Other Medicaments Put Up in Measured Doses or Retail Packings | Summary: The name is explicitly "Medicament," fitting the purpose definition. The HS code prefix matches the pharmaceutical category, and there are no material/shape conflicts. | Specific Dosage Type: Likely refers to a specific sub-type of dosage form not covered by other more specific subheadings in 3004.49. |
| 3004.49.00.40 | Other Medicaments Put Up in Measured Doses or Retail Packings | Summary: The product name directly corresponds to the code's purpose (Medicament), with no material or shape conflicts. | General Dosage: A general fit for medicaments in measured doses where the specific ingredient isn't the primary differentiator in this specific dataset context. |
🔍 Critical Insight:
- 3003 vs. 3004:
- 3003: Typically for medicaments not in measured doses or retail packings (e.g., bulk powders, solutions, uncut pills) OR specific mixtures.
- 3004: Specifically for medicaments put up in measured doses (e.g., tablets, capsules, syringes) or retail packings.
- Since the input is just "Medicament," the system provides options for both 3003 (bulk/mixed) and 3004 (dosage/retail). You must verify the physical form of your product to choose between these.
💰 III. 2026 Latest Tariff Rate Breakdown (Including Surtaxes & Policy Add-ons)
✅ Applicable Country: United States (US)
✅ Origin: China (CN) (Implied by "122 Tariff" reference, which corresponds to IEEPA Section 122 tariffs on China)
✅ Effective Date: 2025 November 10 onwards (including subsequent imports)
🎯 1. All Listed HS Codes (3003.49.00.00, 3003.90.01.90, 3004.49.00.50, 3004.49.00.70, 3004.49.00.40)
| Item | Detail |
|---|---|
| Base Tariff Rate | 0.0% |
| Section 122 Tariff (IEEPA) | +10.0% |
| Section 301 Tariff (USITC) | 0.0% (Note: Data provided shows 0.0% for Section 301 for these specific codes in this dataset) |
| Total Tax Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Eligibility | ❌ Not Applicable (Section 122 tariffs typically override de minimis thresholds for certain goods, or are applied regardless) |
| Legal Basis Path | IEEPA:122 → USITC:3003/3004 |
📌 Explanation:
- "Base Tariff 0%": Under normal Most Favored Nation (MFN) treatment, many pharmaceutical products have 0% base duty.
- "Section 122 Tariff 10%": This is the critical cost driver. Section 122 of the Trade Expansion Act (implemented via IEEPA) imposes an additional 10% tariff on many goods imported from China, including many pharmaceuticals.
- "Section 301 0%": Unlike electronics or machinery, some pharmaceutical items may not be subject to the additional 25% Section 301 tariffs, or are excluded in this specific dataset. However, always verify the latest USITC exclusions list, as policies change.
- Total Effective Rate: 10%. This is a significant cost that must be factored into your landed cost calculation.
🛠️ IV. Customs Clearance Operational Advice (Practical Pitfall Avoidance Guide)
✅ 1. Required Documentation Checklist (Non-negotiable)
| Document | Must Provide | Explanation |
|---|---|---|
| ✅ Product Specification Sheet | ✔️ | Must include: Active ingredients, concentration, form (tablet, liquid, powder), dosage, and intended use. |
| ✅ FDA Approval/Listing Status | ✔️ | FDA Drug Listing ID (DLC), NDC (National Drug Code), or FDA Approval Letter. Crucial for FDA compliance. |
| ✅ Certificate of Analysis (COA) | ✔️ | To verify purity, potency, and composition, especially if misclassification is suspected. |
| ✅ Commercial Invoice | ✔️ | Must clearly state "Medicament," HS Code, Country of Origin (China), and CIF value. |
| ✅ Packing List | ✔️ | Detail the number of units, weight, and packaging type (retail vs. bulk). |
| ✅ Drug Master File (DMF) or FDA Prior Notice | ✔️ | For food/drug imports, FDA Prior Notice is mandatory. DMF may be required for complex formulations. |
| ✅ Labeling Compliance | ✔️ | Labels must meet FDA requirements (English, ingredients, warnings, manufacturer info). |
✅ 2. Declaration Tips (Key Mantras)
🔥 "Form Determines Code, Ingredients Determine Subhead, FDA Determines Clearance!"
| Scenario | Correct Declaration | Wrong Approach |
|---|---|---|
| Tablets/Capsules (Retail) | 3004.49.00.x0 |
Declaring as 3003 (Bulk) → Misclassification Risk |
| Bulk Powder/Unmixed | 3003.49.00.00 or 3003.90.01.90 |
Declaring as 3004 (Dosage) → Misclassification Risk |
| Alkaloid-Containing | 3003.49.00.00 (if not dosage) |
Declaring as general 3003.90 → Potential Audit Trigger |
| Generic "Medicament" | Specify form: "Medicament, Tablets, Contains [Ingredient]" | Vague description: "Medicine" → Delays & Penalties |
📌 Note:
- If your product is in retail packaging (e.g., a box of 30 tablets), it must be declared under 3004.
- If it is bulk (e.g., 1kg of powder for compounding), it may fall under 3003.
- The 10% Section 122 tariff applies regardless of whether it is 3003 or 3004 in this dataset.
✅ 3. Special Case Handling
| Scenario | Handling Advice |
|---|---|
| OEM Custom Medicament | Provide client contract + formula sheet. Ensure NDC/FDA listing matches the importer of record. |
| Herbal/Dietary Supplement vs. Medicament | Critical! If it claims to treat/prevent disease, it is a Drug (HS 3003/3004). If it claims to support health but not treat disease, it may be a Supplement (HS 2106 or 2936). Misclassification here leads to FDA seizure. |
| Biologics | If the medicament is a biological product (e.g., vaccine, blood derivative), ensure correct biological classification. Some may fall under different subheadings. |
| Expedited Shipping | Not Eligible for De Minimis ($800) if Section 122 tariffs apply or if FDA regulation triggers. All shipments must be formally entered. |
🌍 V. Global Market Customs Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff | Regulatory Body | Notes |
|---|---|---|---|---|
| 🇺🇸 USA | 3003.49.00.00 / 3004.49.00.x0 |
10% (Section 122) | FDA | Strict FDA compliance required. 10% tariff is significant. |
| 🇨🇳 China | 3003/3004 |
0-10% | NMPA | Import duties vary. NMPA approval needed. |
| 🇪🇺 EU | 3003/3004 |
0-6.5% | EMA | Generally lower base tariffs. No Section 122 equivalent. |
| 🇬🇧 UK | 3003/3004 |
0-6.5% | MHRA | Post-Brexit rules apply. MHRA registration required. |
| 🇦🇺 Australia | 3003/3004 |
0-5% | TGA | TGA approval mandatory. Low tariffs. |
📌 Conclusion:
- The USA has the highest explicit additional tariff (10%) for Chinese-origin medicaments due to Section 122.
- Regulatory Compliance (FDA) is as critical as tariff payment. Non-compliance leads to detention, destruction, or legal action, not just fines.
📌 VI. Common Errors & Pitfall Avoidance (Lessons Learned)
❌ Error 1: Declaring a Tablet as a Bulk Powder (3003 instead of 3004)
👉 Consequence: Misclassification penalty, potential FDA hold, and incorrect tariff application.
❌ Error 2: Using "Supplement" to avoid FDA Drug Regulations
👉 Consequence: If labels or marketing claims indicate "treatment" or "prevention of disease," FDA will classify it as a Drug, leading to seizure and injunctions.
❌ Error 3: Ignoring the Section 122 Tariff in cost calculations
👉 Consequence: Unexpected 10% additional cost at customs, eroding profit margins.
❌ Error 4: Vague Declaration: "Medicine"
👉 Consequence: Customs cannot determine the correct subheading (3003 vs 3004, or specific ingredient subheadings) → Inspection delays, potential reclassification, and audits.
✅ Correct Practice:
"Medicament, Tablets, Contains [Active Ingredient], 500mg, for Oral Use, Retail Pack, NDC: XXXXX, FDA Approved, Model XYZ"
🎯 VII. Conclusion: Precise Classification, Smooth Clearance, Cost Control!
🎯 Remember These Mantras:
🔹 "Form is King: Tablets = 3004, Bulk = 3003."
🔹 "FDA First: No FDA Approval, No Entry."
🔹 "10% is Real: Budget for Section 122 Tariff."
🔹 "Ingredients Matter: Alkaloids have specific codes."
📌 Pro Tip:
If your medicament is originating from Vietnam, Mexico, or Thailand, you may avoid the Section 122 Tariff, reducing the total duty to 0%~5% (base rate).
Action: Verify the Country of Origin carefully. If it's transshipped from China, it may still be subject to the tariff.
📣 Immediate Action Required:
📞 Engage a Licensed Customs Broker + Provide Full FDA Documentation + Verify HS Code via FDA & CBP Databases.
🚀 Ensure Your Medicament Clears Customs Smoothly, Complies with FDA, and Minimizes Tariff Burden!
✨ Professional Clearance Starts with Precise Classification!
💼 Your Every Cent Saved is the Result of Accurate Declaration!
用户评价
关于 HS 编码归类
协调制度(HS)是由世界海关组织(WCO)制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构:
- 章(2 位)——商品大类(例如:第 84 章:机器和机械设备)
- 品目(4 位)——章内的更具体分类
- 子目(6 位)——国际通用细分,所有 WCO 成员国统一使用
- 本国细分(8-10 位)——各国自行扩展的细分编码,如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时,适用的关税税率可能包括:
- 最惠国(MFN)税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税,如 301 条款(反倾销)、232 条款(国家安全)或反补贴税
本页内容仅供参考。如需正式归类,请咨询当地海关或持牌报关代理。